| Dataset Name | SOTA Method | Metric | Trend | ||
|---|---|---|---|---|---|
| Kidney cancer | RGE-GCN | F1 Score0.913 | 16 | 3mo ago | |
| Lung cancer | RGE-GCN | F1 Score95 | 16 | 3mo ago | |
| Cervical cancer | RGE-GCN | F1 Score92.2 | 16 | 3mo ago | |
| Prostate Cancer Cross-context Average | PC-MIL | B-A Score96.16 | 11 | 1mo ago | |
| Prostate Cancer 1 x 1 mm^2 regional | PC-MIL | B-A Score97.26 | 11 | 1mo ago | |
| Prostate Cancer 2 x 2 mm^2 regional | PC-MIL | B-A Score95.01 | 11 | 1mo ago | |
| Prostate Cancer 4 x 4 mm^2 regional | PC-MIL | B-A Score96.15 | 11 | 1mo ago | |
| Prostate Cancer Slide-level | ABMIL | B-A Score99.46 | 11 | 1mo ago | |
| Micro-US (5-fold cross-validation) | GUIDE-US | AUROC78.4 | 5 | 3mo ago | |
| Colorectal Cancer Prospective experiment | Can-SAVE | Cancers per 1000 Screenings4.3 | 2 | 1mo ago | |
| Lung Cancer Prospective experiment | Can-SAVE | Cancers per 1000 Screenings2.1 | 2 | 1mo ago | |
| Breast Cancer Prospective experiment | Can-SAVE | Cancers per 1000 Screenings1.7 | 2 | 1mo ago | |
| 12-month prospective pilot (426,210 patients) | Invited Patients320,515 | 2 | 1mo ago |
